Fecal microbiomes of laboratory beagles receiving antiparasitic formulations in an experimental setting-Reference-Cited by-同舟云学术

Fecal microbiomes of laboratory beagles receiving antiparasitic formulations in an experimental setting

Published:2024-01-17 Issue:1 Volume:13 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Ottesen Andrea¹^ORCID,Kocurek Brandon¹^ORCID,Deaver Christine¹^ORCID,Chiesa Oscar¹^ORCID,Cohen Rachael¹^ORCID,Reed Elizabeth²^ORCID,Commichaux Seth³^ORCID,Mammel Mark³^ORCID,McDermott Patrick¹^ORCID,Strain Errol²^ORCID,Myers Michael¹^ORCID

Affiliation:

1. Center for Veterinary Medicine, United States Food and Drug Administration , Laurel, Maryland, USA

2. Center for Food Safety and Applied Nutrition, United States Food and Drug Administration , College Park, Maryland, USA

3. Center for Food Safety and Applied Nutrition, United States Food and Drug Administration , Laurel, Maryland, USA

Abstract

ABSTRACT Here, we describe the fecal microbiome of laboratory beagles in a non-invasive experiment designed to contrast in vivo versus in vitro bioequivalence in response to antiparasitic drug administration. The experiment provided a unique opportunity to evaluate metagenomic profiles of canine feces before and after anti-parasitic drug exposure.

Funder

Center for Veterinary Medicine, FDA

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/mra.00860-23

Reference15 articles.

1. Alternate methods for evaluating locally acting non-systemically absorbed drugs in canine disintegrating or chewable single layer combination drug products;Martinez M;Concept Paper for Protocol,2018

2. AAALAC International Standards and Accreditation Process

3. U.S. Department of Health and Human Services . 2015. Public Health service policy on humane care and use of laboratory animals. http://olaw.nih.gov/policies-laws/phs-policy.htm.

4. Extensive impact of non-antibiotic drugs on human gut bacteria

5. Non-antibiotic pharmaceuticals promote the transmission of multidrug resistance plasmids through intra- and intergenera conjugation